Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

210.53
-0.5100-0.24%
Post-market: 210.530.00000.00%19:40 EDT
Volume:1.94M
Turnover:410.08M
Market Cap:10.68B
PE:33.35
High:212.62
Open:210.89
Low:209.84
Close:211.04
52wk High:217.12
52wk Low:144.65
Shares:50.75M
Float Shares:50.75M
Volume Ratio:1.36
T/O Rate:3.82%
Dividend:0.34
Dividend Rate:0.16%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.31
PE(LYR):5.96

Loading ...

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
1 hour ago

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
1 hour ago

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
1 hour ago

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
1 hour ago

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS
·
1 hour ago

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS
·
1 hour ago

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial

TIPRANKS
·
1 hour ago

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
6 hours ago

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Reuters
·
8 hours ago

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
9 hours ago

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Dow Jones
·
9 hours ago

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Reuters
·
9 hours ago

Gilead put volume heavy and directionally bearish

TIPRANKS
·
10 hours ago

Exchange-Traded Funds Higher, US Equities Mixed After Midday

MT Newswires Live
·
12 hours ago

Sector Update: Healthcare

MT Newswires Live
·
13 hours ago

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

TIPRANKS
·
13 hours ago

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Yesterday

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Amid Inflation Data Release

MT Newswires Live
·
Yesterday

MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy

TIPRANKS
·
Yesterday

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Yesterday